Home Massive hepatic infarction in preeclampsia: successful treatment with continuous hemodiafiltration and corticosteroid therapy
Article
Licensed
Unlicensed Requires Authentication

Massive hepatic infarction in preeclampsia: successful treatment with continuous hemodiafiltration and corticosteroid therapy

  • Kei Miyakoshi , Mamoru Tanaka , Akiko Ono , Akiko Ohno , Ryohei Serita , Takeshi Suzuki , Hiroshi Shinmoto , Hiroshi Morisaki and Yasunori Yoshimura
Published/Copyright: September 1, 2004
Journal of Perinatal Medicine
From the journal Volume 32 Issue 5

Abstract

Massive hepatic infarction associated with pregnancy is extremely rare, but is potentially fatal. A 35-year-old primigravida with mild preeclampsia developed acute right upper quadrant pain and marked elevation of liver enzymes at 26 weeks’ gestation. After emergent cesarean section, her condition was complicated by oliguric renal failure and pulmonary edema with further deterioration of hepatic function (aspartate transaminase 4339 IU/L; alanine transaminase 3489 IU/L; lactate dehydrogenase 10780 IU/L). The contrast-enhanced computed tomography revealed non-enhancing low attenuation throughout the right lobe of liver, compatible with infarction. Continuous hemodiafiltration was initiated as renal support on postpartum day one. However, excessive fluid accumulation persisted, and she developed severe edema formation in both lung and systemic body surface. To ameliorate microvascular endothelial injury, corticosteroid therapy was begun on postpartum day five. Following treatment initiation, her renal and hepatic function showed steady improvement, accompanied by drastic resolution of edema formation. She was discharged five weeks postpartum with no additional treatment, and is without sequelae six months later. Massive hepatic infarction should be considered in preeclamptic patients who present acute abdominal pain and severe hepatic dysfunction, and continuous hemodiafiltration with corticosteroid therapy may improve the maternal outcome.

:

Corresponding author: Mamoru Tanaka, MD, Department of Obstetrics and Gynecology, Keio University School of Medicine, 35 Shinanomachi, Shinjuku-ku, Tokyo 160-8582, Japan. Tel: +81-3-3353-1211, FAX: +81-3-3226-1667, E-mail:

References

1 Forni LG, PJ Hilton: Continuous hemofiltration in the treatment of acute renal failure. N Engl J Med336 (1997) 1303Search in Google Scholar

2 Lain KY, J Roberts: Contemporary concepts of the pathogenesis and management of preeclampsia. JAMA287 (2002) 3183Search in Google Scholar

3 Magann EF, KG Perry Jr, EF Meydrech, RL Harris, SP Chauhan, JN Martin Jr: Postpartum corticosteroids: accelerated recovery from the syndrome of hemolysis, elevated liver enzymes, and low platelets (HELLP). Am J Obstet Gynecol171 (1994) 1154Search in Google Scholar

4 Moore K: Renal failure in acute liver failure. Eur J Gastroenterol Hepatol11 (1999) 96710.1097/00042737-199909000-00004Search in Google Scholar PubMed

5 Nakae H, Asanuma Y, Tajimi K: Cytokine removal by plasma exchange with continuous hemodiafiltration in critically ill patients. Ther Apher6 (2002) 419Search in Google Scholar

6 O’Brien JM, Milligan DA, Barton JR: Impact of high-dose corticosteroid therapy for patients with HELLP (hemolysis, elevated liver enzymes, and low platelet count) syndrome. Am J Obstet Gynecol183 (2000) 921Search in Google Scholar

7 Rahman TM, J Wendon: Severe hepatic dysfunction in pregnancy. QJM95 (2002) 343Search in Google Scholar

8 Rolfes DB, KG Ishak: Liver diseases in toxemia of pregnancy. Am J Gastroenterol81 (1986) 1138Search in Google Scholar

Published Online: 2004-09-01
Published in Print: 2004-09-01

© Walter de Gruyter

Articles in the same Issue

  1. Fetal membrane inflammatory cytokines: a switching mechanism between the preterm premature rupture of the membranes and preterm labor pathways
  2. Preeclampsia – abnormal uterine artery Doppler is related to recurrence of symptoms during the next pregnancy
  3. Mother-to-infant vertical transmission of transfusion transmitted virus in South China
  4. Evaluation of second trimester maternal serum screening for Down’s Syndrome using the Spiegelhalter-Knill-Jones (S-KJ) approach
  5. β2-adrenergic receptor gene polymorphisms and pregnancy outcome
  6. Maternal and fetal insulin-like growth factors 1 and 2 (IGF-1, IGF-2) and IGF BP-3, and their relationship to fetal acidosis at delivery
  7. Comparison of intrapartum fetal heart rate tracings in patients with neonatal seizures vs. no seizures: what are the differences?
  8. Computerized cardiotocography parameters in pregnant women affected by pregestational diabetes mellitus
  9. The effect of processing and cryopreservation on nucleated umbilical cord blood cells
  10. Etiology of cerebral palsy
  11. Characterisation of the cytokine inflammatory response in LPS stimulated full-term cord blood
  12. Amniotic cavity cultures, blood cultures, and surface swabs in preterm infants – useful tools for the management of early-onset sepsis?
  13. Massive hepatic infarction in preeclampsia: successful treatment with continuous hemodiafiltration and corticosteroid therapy
  14. The use of recombinant factor VIIa in a primigravida with Glanzmann’s thrombasthenia during delivery
  15. Potential harm from puncture resistant surgical gloves
Downloaded on 12.9.2025 from https://www.degruyterbrill.com/document/doi/10.1515/JPM.2004.146/html
Scroll to top button